Data-driven Targeting of COVID-19 Vaccination Programs: An Analysis of the Evidence on Impact, Implementation, Ethics and Equity
Author/Creator
Author/Creator ORCID
Date
Type of Work
Department
Program
Citation of Original Publication
Rights
This item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
Subjects
Abstract
The data-driven targeting of COVID-19 vaccination programs is a major determinant of the
ongoing toll of COVID-19. Targeting of access to, outreach about and incentives for vaccination
can reduce total deaths by 20-50 percent relative to a first-come-first-served allocation. This
piece performs a systematic review of the modeling literature on the relative benefits of targeting
different groups for vaccination and evaluates the broader scholarly evidence – including
analyses of real-world challenges around implementation, equity, and other ethical
considerations – to guide vaccination targeting strategies. Three-quarters of the modeling studies
reviewed concluded that the most effective way to save lives, reduce hospitalizations and
mitigate the ongoing toll of COVID-19 is to target vaccination program resources to high-risk
people directly rather than reducing transmission by targeting low-risk people. There is
compelling evidence that defining vulnerability based on a combination of age, occupation,
underlying medical conditions and geographic location is more effective than targeting based on
age alone. Incorporating measures of economic vulnerability into the prioritization scheme not
only reduces mortality but also improves equity. The data-driven targeting of COVID-19
vaccination program resources benefits everyone by efficiently mitigating the worst effects of the
pandemic until the threat of COVID-19 has passed.